Notice2024-19624
Meeting of the World Trade Center Health Program Scientific/Technical Advisory Committee
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 3, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting for the World Trade Center Health Program Scientific/ Technical Advisory Committee (STAC). This virtual meeting is open to the public. Time will be available for public comment.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 170 (Tuesday, September 3, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 170 (Tuesday, September 3, 2024)]
[Notices]
[Pages 71277-71279]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-19624]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2024-0064; NIOSH 248-L]
Meeting of the World Trade Center Health Program Scientific/
Technical Advisory Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting for the World Trade Center Health Program Scientific/
Technical Advisory Committee (STAC). This virtual meeting is open to
the public. Time will be available for public comment.
DATES: The meeting will be held on September 23, 2024, from 11 a.m. to
3 p.m., EDT.
Written public comments must be received by September 23, 2024, at
11:59 p.m., EDT. Members of the public who wish to address the STAC
during the oral public comment session must sign up to speak by
September 16, 2024, at the email address provided in the Procedure for
Oral Public Comment section below.
ADDRESSES: This is a virtual meeting conducted via Zoom. The public is
welcome to follow the proceedings via YouTube Live at the following
link: <a href="https://youtube.com/live/7Pokfh4kcsc?feature=share">https://youtube.com/live/7Pokfh4kcsc?feature=share</a>. No
registration is required. For additional information, please visit the
World Trade Center Health Program website at <a href="https://www.cdc.gov/wtc/stac_meeting.html">https://www.cdc.gov/wtc/stac_meeting.html</a>.
You may submit comments, identified by Docket No. CDC-2024-0064;
NIOSH 248-L by either of the methods listed below. CDC does not accept
comments by email.
<bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Follow the instructions for submitting comments.
<bullet> Mail: Ms. Sherri Diana, NIOSH Docket Office, National
Institute for Occupational Safety and Health, Centers for Disease
Control and Prevention, 1090 Tusculum Avenue, Mailstop C-34,
Cincinnati, Ohio 45226. Attn: Docket No. CDC-2024-0064; NIOSH 248-L.
Instructions: All submissions received must include the Agency name
and docket number (CDC-2024-0064; NIOSH 248-L). The docket will close
on
[[Page 71278]]
September 23, 2024. All relevant comments, including any personal
information provided, will be posted without change to <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
FOR FURTHER INFORMATION CONTACT: Tania Carre[oacute]n-Valencia, Ph.D.,
M.S., Designated Federal Officer, World Trade Center Health Program
Scientific/Technical Advisory Committee, National Institute for
Occupational Safety and Health, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, Mailstop R-12, Atlanta, Georgia
30329-4027. Telephone: (513) 841-4515; Email: <a href="/cdn-cgi/l/email-protection#621516014f11160301220106014c050d14"><span class="__cf_email__" data-cfemail="bccbc8df91cfc8dddffcdfd8df92dbd3ca">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Background: The World Trade Center (WTC) Health Program, including
the WTC Health Program Scientific/Technical Advisory Committee (STAC),
was established by title I of the James Zadroga 9/11 Health and
Compensation Act of 2010, Public Law 111-347, as amended by Public Law
114-113, Public Law 116-59, Public Law 117-328, and Public Law 118-31,
adding title XXXIII to the Public Health Service (PHS) Act (codified at
42 U.S.C. 300mm to 300mm-64). Title XXXIII of the PHS Act established
the WTC Health Program within the Department of Health and Human
Services. The WTC Health Program provides medical monitoring and
treatment benefits to eligible firefighters and related personnel, law
enforcement officers, and rescue, recovery, and cleanup workers who
responded to the September 11, 2001, terrorist attacks in New York
City, at the Pentagon, and in Shanksville, Pennsylvania (responders),
and to eligible persons who were present in the dust or dust cloud on
September 11, 2001, or who worked, resided, or attended school,
childcare, or adult daycare in the New York City disaster area
(survivors).
All references to the Administrator in this document mean the
Director of the National Institute for Occupational Safety and Health
(NIOSH), within the Centers for Disease Control and Prevention (CDC),
or his or her designee.
Purpose: The purpose of the STAC is to review scientific and
medical evidence and to make recommendations to the Administrator of
the WTC Health Program regarding additional WTC Health Program
eligibility criteria, potential additions to the List of WTC-Related
Health Conditions (List), and research regarding certain health
conditions related to the September 11, 2001, terrorist attacks. In
accordance with section 3312(a)(6)(G)(i)(II) of the PHS Act, the
Administrator must ask the STAC to review and evaluate any substantive
amendment to any existing WTC Health Program policy or procedure used
to determine whether sufficient evidence exists to support adding a
health condition to the List of WTC-Related Health Conditions.
The Administrator is responsible for the administration of the
STAC. CDC and NIOSH provide funding, staffing, and administrative
support services for the Committee. The STAC's charter was reissued on
May 12, 2023, and will expire on May 12, 2025.
Matters to Be Considered: The agenda will include updates on the
status of WTC Health Program Research and the Youth Research Cohort. It
will include a presentation on the expansion of the WTC Health Program
enrollment eligibility for Pentagon and Shanksville responders. In
addition, there will be a presentation about non-substantive revisions
to the existing Policy and Procedures for Adding Non-Cancer Health
Conditions to the List of WTC-Related Health Conditions.
Background documents as well as the agenda for this meeting are
available on the WTC Health Program website at <a href="https://www.cdc.gov/wtc/stac_meeting.html">https://www.cdc.gov/wtc/stac_meeting.html</a>. Agenda items are subject to change as priorities
dictate.
Public Participation
Interested parties may participate by submitting written views,
opinions, recommendations, and data. You may submit comments on any
topic related to the matters to be discussed by the Committee. Comments
received, including attachments and other supporting materials, are
part of the public record and subject to public disclosure. Do not
include any information in your comment or supporting materials that
you consider confidential or inappropriate for public disclosure. If
you include your name, contact information, or other information that
identifies you in the body of your comments, that information will be
on public display. CDC will review all submissions and may choose to
redact, or withhold, submissions containing private or proprietary
information such as Social Security numbers, medical information,
inappropriate language, or duplicate/near-duplicate examples of a mass-
mail campaign. CDC will carefully consider all comments submitted into
the docket.
Oral Public Comment: The public is welcome to participate, via
Zoom, during the public comment period on September 23, 2024, from 1:15
p.m. to 1:45 p.m., EDT. Each commenter will be provided up to five
minutes for comment. A limited number of time slots are available and
will be assigned on a first-come, first-served basis.
Procedure for Oral Public Comment: Members of the public who wish
to address the STAC during the oral public comment session at the
September 23, 2024, STAC meeting must sign up to speak by providing
their name to Ms. Mia Wallace, Committee Management Specialist, via
email at <a href="/cdn-cgi/l/email-protection#2e63794f42424f4d4b6e4d4a4d00494158"><span class="__cf_email__" data-cfemail="4d001a2c21212c2e280d2e292e632a223b">[email protected]</span></a>, by September 16, 2024. Zoom instructions and
participation details will follow.
Written Public Comment: Written comments will also be accepted per
the instructions provided in the Addresses section above. Written
public comments received prior to the meeting will be part of the
official record of the meeting. The docket will close on September 23,
2024.
Policy on Redaction of Committee Meeting Transcripts (Public
Comment): Transcripts will be prepared and posted to <a href="https://www.regulations.gov">https://www.regulations.gov</a> within 60 days after the meeting. If individuals
making a comment give their name, no attempt will be made to redact the
name. NIOSH will take reasonable steps to ensure that individuals
making public comments are aware that their comments (including their
names, if provided) will appear in a transcript of the meeting posted
on a public website. Such reasonable steps include a statement read at
the start of the meeting stating that transcripts will be posted, and
that names of speakers will not be redacted. If individuals in making a
statement reveal personal information (e.g., medical information) about
themselves, that information will not usually be redacted. The CDC
Freedom of Information Act coordinator will, however, review such
revelations in accordance with the Freedom of Information Act and, if
deemed appropriate, will redact such information. Disclosures of
information concerning third-party medical information will be
redacted.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
[[Page 71279]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-19624 Filed 8-30-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 3, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.